Corcept Therapeutics, Inc. (CORT)
113.34
-0.54
(-0.47%)
USD |
NASDAQ |
Aug 31, 16:00
113.34
0.00 (0.00%)
After-Hours: 18:59
Corcept Therapeutics Cash from Investing (Quarterly) : -29.24M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.24M |
| March 31, 2026 | 4.542M |
| December 31, 2025 | -11.84M |
| September 30, 2025 | 14.64M |
| June 30, 2025 | 70.13M |
| March 31, 2025 | -3.171M |
| December 31, 2024 | -64.36M |
| September 30, 2024 | -44.04M |
| June 30, 2024 | -60.19M |
| March 31, 2024 | -9.014M |
| December 31, 2023 | 17.10M |
| September 30, 2023 | -109.57M |
| June 30, 2023 | -24.10M |
| March 31, 2023 | 207.48M |
| December 31, 2022 | -17.24M |
| September 30, 2022 | -4.79M |
| June 30, 2022 | -41.80M |
| March 31, 2022 | -50.50M |
| December 31, 2021 | 140.47M |
| September 30, 2021 | -25.80M |
| June 30, 2021 | 24.74M |
| March 31, 2021 | -3.284M |
| December 31, 2020 | 11.22M |
| September 30, 2020 | -64.27M |
| June 30, 2020 | -85.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 19.73M |
| December 31, 2019 | -61.99M |
| September 30, 2019 | -54.32M |
| June 30, 2019 | -1.156M |
| March 31, 2019 | -0.367M |
| December 31, 2018 | -1.757M |
| September 30, 2018 | -33.51M |
| June 30, 2018 | -21.21M |
| March 31, 2018 | -34.29M |
| December 31, 2017 | -27.45M |
| September 30, 2017 | -11.65M |
| June 30, 2017 | -14.95M |
| March 31, 2017 | -19.41M |
| December 31, 2016 | -0.075M |
| September 30, 2016 | -0.09M |
| June 30, 2016 | -0.007M |
| March 31, 2016 | -0.022M |
| December 31, 2015 | 0.017M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -0.034M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.016M |
| June 30, 2014 | -0.048M |
| March 31, 2014 | -0.11M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Liquidia Corp. | -12.24M |
| Eli Lilly & Co. | -15.40B |
| Abeona Therapeutics, Inc. | 15.69M |
| Indivior Pharmaceuticals, Inc. | -7.942M |
| Crinetics Pharmaceuticals, Inc. | 26.29M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 33.54M |
| Cash from Financing (Quarterly) | -2.037M |
| Free Cash Flow | 106.92M |
| Free Cash Flow Per Share (Quarterly) | 0.262 |
| Free Cash Flow to Equity (Quarterly) | 31.23M |
| Free Cash Flow to Firm (Quarterly) | 31.02M |
| Free Cash Flow Yield | 0.82% |